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Based on in situ hybridization histochemistry (ISHH), we describe the anatomical distribution of the serotonin 5-HTic 
receptor mRNA. In addition to the very high levels in epithelial cells of the choroid plexus, 5-HTic receptor mRNA 
is found throughout he limbic system, in catecholaminergic cells and in serotonergic neurons. Receptor transcripts are 
also present in the hypothalamus, numerous motor nuclei and the subthalamus. Our results correlate well with serotonin 
(5-HT) innervation and receptor binding. Receptor mRNA is present in many brain structures in addition to regions 
previously shown to have 5-HTic receptor binding. The distribution of this receptor mRNA suggests that the 5-HTic 
receptor may mediate a number of the central effects of 5-HT. 
Oligonucleotide; Hybridization 
1. INTRODUCTION 
Serotonergic innervation is widespread through- 
out the central nervous system (CNS) and the 
periphery. Serotonin has been implicated in 
smooth muscle contraction, nociception, appetite, 
thermoregulation, sleep, sexual behavior, memory, 
anxiety, depression and hallucinogenic behavior 
[l-3]. In addition to its direct effects as a neuro- 
transmitter, serotonin autoregulates 5-HT neu- 
rons, interacts with other neurotransmitter systems 
and facilitates motor and sensory neurotransmis- 
sion [4,5]. Recently, mitogenic effects of 5-HT 
have also been demonstrated [6,7]. 
Several receptors and binding sites for serotonin 
have been defined on the basis of pharmacological 
and physiological criteria [8]. Following the initial 
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classification of serotonin-binding sites into 5-HTr 
and 5-HT2 [9], at least four subtypes of the 5-HTi 
sites, denoted lA-D, have been characterized in 
the mammalian brain. In addition, 5-HTs [lo] 
receptors have been described in rat brain. Altera- 
tions in serotonin receptor levels have been de- 
scribed in relation to depression [11,121, in normal 
aging processes [ 13- 151 and in some [ 161 but not all 
[17] suicide victims. Furthermore, changes in 5-HT 
receptor levels have also been associated with 
Alzheimer’s disease [ 18,191, Huntington’s chorea 
[20] and schizophrenia [21]. However, the con- 
tribution of each receptor subtype to normal and 
disease processes is not understood. 
The 5-HTrc-binding site was first characterized 
in pig [22] and rat [23] choroid plexus. Present at 
extremely high densities on the epithelial cells of 
the choroid plexus, the 5-HTrc-binding site is a 
functional receptor which mediates phospho- 
inositide turnover in both rat [24] and pig [25]. Al- 
though the 5-HTrc receptor may regulate cerebro- 
spinal fluid production by the choroid plexus [26], 
the physiological role of this receptor in the brain is 
not known. Considerably lower levels of binding 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/%3.50 0 1989 Federation of European Biochemical Societies 453 
Volume 247, number 2 FEBS LETTERS April 1989 
sites have been identified in regions of human and 
rat brain [27,28] than in the choroid plexus. 
Recently, the structure of the 5-HTlc receptor 
has been deduced by molecular cloning of cDNAs 
from rat [29] and mouse [25]. Based on these 
nucleic acid sequences, we have designed two oligo- 
nucleotide probes for in situ hybridization histo- 
chemistry (ISHH). Here, we describe the distribu- 
tion of neurons containing this serotonin receptor 
and correlate these results with serotonergic inner- 
vation, 5-HTK receptor binding studies and 
physiological processes influenced by serotonin. 
Our data suggest that the 5-HTK receptor may 
mediate a number of the central effects of sero- 
tonin. 
2. MATERIALS AND METHODS 
2.1. Oligonucleotide probes 
The deduced amino acid sequence of the serotonin 5-HTlc 
receptor predicts seven transmembrane s gments with structural 
similarity to other members of the G-protein-coupled receptor 
family. At the amino acid level, the transmembrane r gions are 
most highly conserved among family members, while the amino- 
and carboxy-termini and the large third cytoplasmic loop are 
poorly conserved. In order to design probes specific for the 
5-HTIC receptor, sequences for oligonucleotides were chosen 
from the carboxy-terminus (denoted 3A) and the third cytoplas- 
mic loop (termed 2B). Avoiding homology to other known 
receptors, especially the 5-HT2 receptor subtype [30], two 
48-base oligonucleotides (2B, 5 ‘-ATTAGCCAGTTCCTCCTC- 
GGTGTGACCTCGAAGTAACATCAGAGTTTG-3 ‘; 3A, 5 ‘- 
GAGCTCCCTCCCAGACAAAGCAGTGGCAGCAACCCT- 
AGGAATCTGTCG-3’) were prepared using an Applied Bio- 
systems DNA synthesizer. Probes for ISHH were A-tailed for 
5 min at 37°C as described [31]. Specific activities were 
8 x lo5 cpm/pmol for probe 2B and 1 x lo6 cpm/pmol for 
probe 3A. 
2.2. In situ hybridization histochemistry 
Sections of fresh-frozen adult rat brains (male Sprague- 
Dawley) were cut thaw-mounted onto gelatin-coated slides and 
stored at - 80°C. Prior to hybridization, sections were warmed 
to room temperature, fixed in 4% formaldehyde then de- 
hydrated as in 1321. 4 x 10’ cpm ‘%-labeled probe were applied 
to each section in hybridization buffer [50% formamide/0.6 M 
NaCY0.06 M sodium citrate/50 mM sodium phosphate (pH 
6.5)/50 mM dithiothreitol/O.O2qo Ficoll/0.02% polyvinylpyr- 
rolidone/0.02% bovine serum albumin/lO% dextran sul- 
fate/250 pg/ml yeast tRNA/SOO fig/ml sheared single-stranded 
salmon sperm DNA]. Hybridizations were performed for 24 h 
at 37°C. Sections were washed four times for 15 min at 40°C in 
50% formamide/0.3 M NaCl/0.3 M sodium citrate and twice 
for 1 h at room temperature in 0.15 M NaCl10.015 M sodium 
citrate. Sections were opposed to Kodak XAR film for 2.5 days, 
then dipped in Kodak NTB3 nuclear emulsion (1: 1 with water). 
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After exposure at 4°C for 13 days, sections were developed us- 
ing Kodak D-19 developer (1: 1 with water), fixed and counter- 
stained with 0.2% toluidine blue. 
3. RESULTS 
Probes specific for the carboxy-terminus (3A) 
and the third cytoplasmic loop (2B) of the 5-HT1, 
receptor hybridize to identical cells in adjacent hin 
sections (4 pm) from septal areas (fig.1) as well as 
brainstem and hippocampus (not shown). In addi- 
tion, RNA blot analysis of poly (A+) RNA from 
choroid plexus, cortex and hippocampus reveals a 
single hybridizing band of about 5.2 kb (not 
shown) using probe 3A. Taken together, these data 
indicate that probes 2B and 3A specifically hybri- 
dize to a single mRNA for the serotonin 5-HT1, 
receptor. 
In addition to the choroid plexus, serotonin 
receptor mRNA is present in many neuronal cell 
bodies throughout the rat brain (fig.2). A detailed 
description follows. 
3.1. Telencephalon 
Among rhinencephalic structures, the olfactory 
bulb, olfactory nuclei (fig.2, panel 1) and olfactory 
tubercle (panels l-3) express intermediate levels of 
mRNA. The nucleus of the diagonal tract (panel 2) 
also contains intermediate levels of transcripts. 
Within the hippocampus (panels 9-12), the dentate 
gyrus, subiculum and layers CA2 and CA3 (fig.3D) 
show high levels of mRNA while layer CA1 has 
lower levels. Whereas the frontopolar cortex (panel 
1) contains little hybridization, the internal layers 
of the cingulate cortex (panels 6-10) and pyriform 
cortex (panels 2-5) contain intermediate amounts. 
The regions of the basal ganglia (panels 3-6) vary 
greatly in their expression of serotonin 5-HT1, 
receptor mRNA. As seen in panel 2, the nucleus ac- 
cumbens has intermediate levels of labeling while 
the endopyriform nucleus (panel 6) contains high 
levels of grains and the claustrum (panel 6) has in- 
termediate levels. Both the caudate-putamen (panel 
3-6) and globus pallidus (panels 3-6) contain scat- 
tered cells that hybridize to the probe. The subfor- 
nical organ has a high level of transcripts while in 
the septum, the dorsal and lateral nuclei have in- 
termediate amounts, and the medial and triangular 
nuclei have low amounts of mRNA (panels 3-5). 
All nuclei of the amygdala (panels 7,8) show at 
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Fig.1. Two oligonucleotide probes for serotonin S-HTlc receptor mRNA identify the same cells in serial rat brain sections. 
Photomicrograph of adjacent coronal sections (4/m) from adult rat brain hybridized with either (A) probe 2B or (B) probe 3A as 
described. Arrows indicate several of the numerous cells in the septal area which are labeled by both probes. The choroid plexus (CH) 
is shown for orientation. 
least low levels of receptor mRNA; cells of the cen- 
tral and basal (fig.3G) nuclei have intermediate to 
high levels of hybridization. In addition, the bed 
nucleus of the stria terminalis (panel 4) has in- 
termediate levels of hybridization. 
3.2. Diencephaion 
The thalamus (panels 5-10) contains in- 
termediate levels of labeling in the periventricular 
and centromedial nuclei as well as the reuniens 
nucleus. Intermediate levels of labeling are found 
throughout the reticular formation. The lateral 
habenula (panels 8,9 and fig.3F) shows high levels 
of transcripts as seen by Julius et al. 1291. However, 
low levels predominantly in a crescent-shaped 
region of the lateral portion of the medial habenula 
455 
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are also observed. Both the lateral (panel 10) and nucleus (panel 13) have low levels of transcripts. 
medial (panels 11,12) geniculate bodies xpress in- Both the inferior (panel 13) and superior (panel 12) 
termediate levels of serotonin 5-HTr, receptor colliculi express intermediate levels of mRNA. In- 
mRNA. In the subthalamus (panels 7-lo), the zona termediate densities of mRNA are found in the 
incerta has intermediate levels of hybridization, dopamine-rich substantia nigra (panel 11 and 
but the entopeduncular nucleus (fig.3K) contains fig.3A) as well as the catecholaminergic nuclei such 
high levels of receptor mRNA. as A7 and A8 (panels 11-13 and fig.3B). 
High levels of mRNA transcripts are found in 
numerous nuclei throughout the hypothalamus. 
Within the preoptic region (panel 3), the medial 
and lateral preoptic nuclei show low levels of label- 
ing. The median forebrain bundle (panels 5-10 and 
fig.31), the mammillary body and the anterior 
hypothalamic nuclei (panels 4,5) produce in- 
termediate levels of receptor mRNA. Similar 
amounts of labeling are observed in the region of 
the parvocellular CRF-producing cells of the 
paraventricular nucleus (panel 6 and fig.3J) and in 
the magnocellular hypothalamic neurons. The ven- 
tromedial region of the suprachiasmatic nucleus, 
most likely the vasopressin-producing cells, shows 
intermediate labeling (panels 4,5). The dor- 
somedial nucleus (panel 6) expresses high levels of 
serotonin 5-HTr, receptor mRNA. 
3.4. Pons 
Several regions of the pons express low to in- 
termediate levels of serotonin 5-HTr, receptor 
mRNA. The pontine nuclei (panel 12) and the 
superior olive (panel 14) show low amounts of 
hybridization. Other regions which have interme- 
diate levels of transcripts include the pontine raphe 
nucleus (panel 13), locus coeruleus (panel 14), the 
dorsal and ventral parabrachial nuclei (panels 
14-16), and the trigeminal motor nucleus (panels 
15,16). Like the midbrain, the reticular formation 
of the pons contains numerous cells which express 
this serotonin receptor mRNA. 
3.5. Cerebellum 
3.3. Mesencephalon 
Within the mesencephalon (panels 1 l-13), 
numerous regions have receptor mRNA ranging 
from low to very high levels. The ventral tegmental 
area (panel 11) and the periaqueductal grey (panels 
11,12) show low levels. Within the oculomotor 
nucleus complex, the Edinger-Westphal nucleus 
(panel 12) contains intermediate levels of mRNA. 
Of the most anterior raphe nuclei, the dorsal raphe 
(panels 12,13) has intermediate levels while the 
linear raphe nucleus (panels 11,12 and fig.3E) has 
high levels of mRNA. The interpeduncular nucleus 
(panels 11,12) which borders the linear raphe 
nucleus contain only low levels of hybridization. 
The red nucleus (panel 12) and the cuneiform 
In general, the cerebellum (panels 14-17) has the 
least number of transcripts of the major structures 
of the brain. In the cerebellar cortex, low levels of 
mRNA are found in a few scattered granule cells. 
The cerebellar nuclei have intermediate levels of 
transcripts. 
3.6. Medulla oblongata 
The cochlear and vestibular nuclei (panels 15,16) 
produce low levels of mRNA. The three raphe 
nuclei of the medulla oblongata, raphe obscurus 
(not shown), raphe pallidus (not shown) and raphe 
magnus (panels 14-16 and fig.3H), have interme- 
diate to high levels of receptor transcripts. As in the 
pons and midbrain, reticular formation in the 
medulla shows intermediate levels of mRNA with 
the majority of hybridization in the lateral reticular 
Fig.2. Localization of serotonin 5-HT ic receptor mRNA throughout adult rat brain. Low-magnification autoradiograms of 12-pm cor- 
onal sections (cut at 200-pm intervals) hybridized with probe 3A as described. Sections are arranged in rostra1 to caudal order (panels 
1-18) with schematic anatomical drawings for orientation. Choroid plexus is identified in several panels by arrowheads. Key for iden- 
tified structures: A, amygdala; A7, A8, midbrain catecholaminergic cell groups; B, bed nucleur of the stria terminalis; c, central canal; 
C, cingulate cortex; CA, caudate nucleus; Cer, cerebellum; D, dorsomedial hypothalamic nucleus; E, endopyriform nucleus; EP, en- 
dopeduncular nucleus; H, habenula; Hi, hippocampus; IC, inferior collicle; L, lateral geniculate body; lr, linear raphe nucleus; M, 
medial geniculate body; MF, median forebrain bundle; nc, commisural part of solitary tract; nts, nucleus of the solitary tract; o, olfac- 
tory bulb; ot, olfactory tubercle; P, paraventricular nucleus; PO, preoptic area; RM, raphe magnus; S, septum; SC, superior collicle; 
T, thalamus; ts, nucleus of the spinal trigeminal tract; V, vestibular nuclei; Z, zona incerta. 
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nucleus (panels 16,17). The nuclei of the solitary 
tract (panels 16-18) have intermediate levels of 
hybridization with highest amounts of mRNA in 
the commissural nucleus (panel 18 and fig.3C). The 
neurons of the brainstem motor nuclei express in- 
termediate to high levels of the receptor mRNA 
(panels 14-18 and fig.3C). 
and cerebellum by RNA blot analysis [29], a 
method that is less sensitive than ISHH. While the 
cortex, olfactory bulb, olfactory tubercle and 
cerebellum are not devoid of 5-HTK receptor 
mRNA, these regions seem to contain populations 
of cells with little or no mRNA. 
4. DISCUSSION 
The serotonin 5-HTic receptor is expressed in 
choroid plexus epithelial cells and numerous 
neurons throughout the CNS (figs.2,3). As demon- 
strated by immunocytochemistry, the majority of 
serotonergic cell bodies are concentrated in the 
raphe nuclei and innervate nearly all regions of the 
CNS [33,34]. There is particularly dense innerva- 
tion of the limbic system including the septal area 
and amygdala in addition to median forebrain bun- 
dle, thalamus, hypothalamus, interpeduncular 
nucleus, the solitary tract nucleus, locus coeruleus, 
and the lateral reticular formation. Localization of 
serotonin 5-HTic receptor mRNA in rat brain by 
ISHH correlates very well with serotonergic inner- 
vation. That is, 5-HTic receptor mRNA is not 
present in areas which do not receive S-HT innerva- 
tion. Conversely, not all areas receiving 5-HT in- 
nervation contain 5-HTm receptor mRNA. For in- 
stance, layer V [35] of cortex shows 5-HT immuno- 
reactivity as well as post-synaptic 5-HTz receptors, 
but our probes show very little hydridization in this 
region. This observation further confirms the 
specificity of these probes for 5-HTK receptor 
mRNA. In addition, electrophysiological response 
to microiontophoresis of serotonin have been 
recorded from cells in a number of brain regions 
which both receive serotonin innervation and ex- 
press 3-HTic receptor mRNA including hippocam- 
pus, amygdala, septum, olfactory bulb, hypo- 
thalamus, thalamus, striatum, cuneate nucleus, 
dorsal lateral geniculate, superior colliculus, dorsal 
raphe nucleus and reticular formation neurons 
[331. 
The distribution of serotonin 5-HTK receptors 
has been characterized by receptor autoradiogra- 
phy [27,28]. The choroid plexus has the highest 
level of specific binding while several other regions 
have at least IO-fold lower receptor site densities. 
Although receptor mRNA is co-localized in most 
of the regions which also display specific binding, 
many more areas of the brain express 5-HTic 
receptor transcripts than display receptor binding. 
For instance, the suprachiasmatic nucleus, septum 
and dentate gyrus (figs.2,3) express high levels of 
receptor mRNA, but little or no specific binding 
has been shown in these regions. The increased sen- 
sitivity and cellular resolution of ISHH using 35S- 
labeled probes as compared to ‘H-radioligands 
may account for these differences. However, 
mRNA levels need not be proportional to receptor 
number and receptor protein may be present in 
structures distant from the cell body transcribing 
the specific mRNA. 
A role for serotonin has been implicated in 
mood, behavior and hallucinogenic effects [l-3], 
functions generally associated with the limbic 
system. With the exception of the choroid plexus, 
the highest levels of 5-HTic receptor mRNA are in 
the limbic structures: hippocampus, septum, 
amygdala, olfactory nuclei, endopyriform nuclei, 
cingulate cortex, pyriform cortex. Lysergic acid 
diethylamide (LSD) has high affinity for 5-HTic 
receptors and acts as a partial agonist to stimulate 
phosphoinositide turnover in choroid plexus [25]. 
The presence of high levels of receptor mRNA in 
limbic structures is consistent with the suggestion 
that the 5-HTIC receptor may mediate responses to 
psychotropic drugs such as LSD. In addition, 
5-HTIC receptors may play a role in 5-HT-asso- 
ciated affective disorders [1,11,12,16,21]. 
Results from in situ hybridization histochemistry Serotonin has been shown to influence hypotha- 
were also consistent with analysis of RNA ex- lamic associated functions such as sleep, appetite, 
tracted from brain regions [29] showing the highest thermoregulation, sexual behavior and neuroendo- 
levels of RNA in the choroid plexus and lower crine functions [l]. The presence of high levels of 
levels in basal ganglia, pons-medulla, hippocampus 5-HTic receptor mRNA in the medial parvo- 
and hypothalamus. Very little or no 5-HTic recep- cellular region of the paraventricular nucleus 
tor mRNA was detected in cortex, olfactory bulb (PVN) implies a role for this receptor in neuroen- 
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docrine regulation and perhaps stress. Serotonergic 
neurons in the raphe discharge at a slow rhythmic 
rate, suggestive of a pacemaker function in the 
CNS. In addition, the heavy serotonergic inner- 
vation and high levels of receptor mRNA in the 
suprachiasmatic nucleus (NSC) suggest that 
5-HTrc receptors may be important in controlling 
cyclic events (including cyclic changes in the 
reproductive neuroendocrine axis). 
Interestingly, all areas containing serotonin- 
producing cells (i.e. raphe reticular formation and 
even the dorsomedial hypothalamic nuclei) express 
very high levels of 5-HTrc receptor mRNA. Agha- 
janian and co-workers [33] have shown that activa- 
tion of the ~-HTIA receptor on the soma of raphe 
nuclei inhibits firing of serotonergic neurons. 
Similarly, the 5-HTic receptor may modulate or 
autoregulate the activity of serotonergic neurons. 
Serotonin and catecholamines have opposing ef- 
fects in controlling sleep, hypothalamic functions 
and motor activity [l]. Interestingly, the 5-HTIC 
receptor transcript is expressed in all catecholamine 
(CA) cell group areas except for the hypothalamic 
CA cells of the periventricular and arcuate nuclei. 
This receptor may mediate serotonin interactions 
with catecholaminergic ells. 
Prior to the pharmacological characterization of 
serotonin receptor subtypes, Aghajanian [4] had 
described three receptors for 5-HT based on elec- 
trophysiological responses. Occupation of one of 
these receptors found on motoneurons and in the 
reticular formation increased the excitability of 
postsynaptic neurons to other neurotransmitters, 
particularly glutamate. This response is blocked by 
methysergide and cinanserin, classical serotonin 
antagonists. In addition, the ‘motor syndrome’ 
[36], a complex set of motor behaviors elicited by 
5-HT agonists, appears to be mediated by excessive 
facilitation of 5-HTi receptors on motor neurons 
on the brainstem or spinal cord [4]. The hallmark 
of the 5-HTrc receptor is its high affinity for both 
5-HT and clasical 5-HT antagonists [22,23]. It is 
therefore particularly interesting that neurons in 
motor nuclei (oculomotorius, trigeminal, VII, 
vagus and hypoglossal, for example) express high 
levels of 5-HTlc receptor mRNA. In addition, the 
subthalamic structures which are thought to con- 
trol muscle activity [l] also express very high levels 
of this receptor mRNA. Taken toether, these data 
suggest that the 5-HTic receptor may play an im- 
portant role in serotonin effects on motor activity 
and control. 
Serotonin was first identified as a blood-borne 
agent which caused vasoconstriction via receptors 
on the smooth muscle of blood vessels [33]. How- 
ever, the nucleus of the solitary tract which ex- 
presses significant levels of 5-HTic receptor 
mRNA comprises the autonomic component of 
blood pressure control and respiration. Thus, 
serotonin may affect blood pressure and respira- 
tion at the level of this nucleus in addition to affec- 
ting blood vessels directly. 
We have mapped in detail the expression of a 
serotonin receptor mRNA ,in the rat CNS. The 
identification of many neurons expressing this 
receptor subtype suggests that the 5-HTK receptor 
may mediate a number of the central effects of 
serotonin in both normal and pathological condi- 
tions. With this information, it may now be possi- 
ble to dissect the complex role of serotonin in the 
CNS and begin to understand the physiological 
significance of 5-HT receptor subtypes. 
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